Clinical Trials Directory

Trials / Completed

CompletedNCT01816841

Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care

The Role of Direct Visual Fluorescence in Oral Examination

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial studies direct visual fluorescence in finding oral cancer in high-risk patients and patients undergoing routine dental care. Diagnostic procedures, such as direct visual fluorescence, may help find and diagnose oral cancer.

Detailed description

PRIMARY OBJECTIVES: I. To assess the diagnostic benefit of the VELscope (direct visual fluorescence) inspection in oral examination. II. Efficacy of the VELscope in identifying dysplastic (premalignant) and malignant oral mucosal lesions and in discriminating these lesions from common benign tissue changes. III. Accuracy of clinical judgment versus VELscope findings. IV. Ability of the VELscope to identify lesions or extent of lesions beyond what is clinically apparent. OUTLINE: Patients undergo conventional oral examination (COE) followed by direct visual fluorescence examination (DVFE). Patients with tissue abnormalities found by COE or DVFE undergo scalpel biopsy within 2 weeks.

Conditions

Interventions

TypeNameDescription
PROCEDUREfluorescence imagingUndergo DVFE
PROCEDUREbiopsyUndergo scalpel biopsy
PROCEDUREexaminationUndergo COE
PROCEDUREComparison of surgical margins by COE vs. DVFESurgical margin determination using DVFE

Timeline

Start date
2008-11-11
Primary completion
2016-10-03
Completion
2019-12-28
First posted
2013-03-22
Last updated
2020-01-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01816841. Inclusion in this directory is not an endorsement.